Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-01 @ 4:05 PM
Study NCT ID:
NCT02267967
Status:
COMPLETED
Last Update Posted:
2018-11-13
First Post:
2014-10-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors
Sponsor:
Hutchison Medipharma Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2014-012-00CH1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None